Skip to content
Disclosery

EXANE DERIVATIVES: PEG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PEG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13,562 PEG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13,562 shares
    Change vs previous 13F -121 shares

    0.49% of the 13F portfolio, value $858,113.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13,683 shares
    Change vs previous 13F +2,764 shares

    0.27% of the 13F portfolio, value $957,817.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 10,919 shares
    Change vs previous 13F +262 shares

    0.18% of the 13F portfolio, value $728,648.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 10,657 shares
    Change vs previous 13F +1,538 shares

    0.16% of the 13F portfolio, value $649,032.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,119 shares
    Change vs previous 13F +345 shares

    0.13% of the 13F portfolio, value $545,600.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 8,774 shares
    Change vs previous 13F -190 shares

    0.16% of the 13F portfolio, value $528,303.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 8,964 shares
    Change vs previous 13F not available

    0.16% of the 13F portfolio, value $522,620.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).